Article

New CPT code for telescope implant

The American Medical Association (AMA) has released a new Current Procedural Terminology (CPT) code for the procedure used to implant miniature ophthalmic telescopes (Implantable Miniature Telescope [by Dr. Isaac Lipshitz], VisionCare Ophthalmic Technologies).

Saratoga, CA-The American Medical Association (AMA) has released a new Current Procedural Terminology (CPT) code for the procedure used to implant miniature ophthalmic telescopes (Implantable Miniature Telescope [by Dr. Isaac Lipshitz], VisionCare Ophthalmic Technologies).

The new CPT code, 0308T, Insertion of ocular telescope prosthesis including removal of crystalline lens, became effective July 1. The ophthalmic telescope implant is indicated to improve vision in patients who have end-stage age-related macular degeneration (AMD).

“The issuance of a specific CPT code by AMA, along with Medicare’s previous granting of a pass-through payment mechanism, helps to solidify hospital and provider reimbursement for the telescope implant procedure,” said Allen W. Hill, chief executive officer of VisionCare. “These reimbursement milestones support the telescope implant as a standard of care for patients who cannot be helped by other AMD therapies and who meet medical eligibility criteria. We look forward to continuing to work with health-care institutions and providers with this additional reimbursement coding in place that facilitates treatment provision to patients whose quality of life can be improved with the telescope implant.”

Providers and patients can find more information about the telescope implant and related treatment program at www.centras ight.com.

For more articles in this issue of Ophthalmology Times eReport, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.